Artificial Heart and Ventricular Assist Devices Market

An artificial heart is a device that replaces the heart. Artificial hearts are typically used to bridge the time to heart transplantation, or to permanently replace the heart in case heart transplantation is impossible. A ventricular assist device (VAD) ? also known as a mechanical circulatory support device ? is an implantable mechanical pump that helps pump blood from the lower chambers of your heart (the ventricles) to the rest of your body. A VAD is used in people who have weakened hearts or heart failure.
Artificial Heart and Ventricular Assist Devices Market contains market size and forecasts of Artificial Heart and Ventricular Assist Devices in global, including the following market information:
Global Artificial Heart and Ventricular Assist Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Artificial Heart and Ventricular Assist Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Artificial Heart and Ventricular Assist Devices companies in 2021 (%)
The global Artificial Heart and Ventricular Assist Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Artificial Heart Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Heart and Ventricular Assist Devices include SynCardia Systems, Medtronic PLC, Abbott Laboratories, BiVACOR, Berlin Heart, ABIOMED, LivaNova PLC, CARMAT and Jarvik Heart Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Artificial Heart and Ventricular Assist Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Heart and Ventricular Assist Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Heart and Ventricular Assist Devices Market Segment Percentages, by Type, 2021 (%)
Artificial Heart
Ventricular Assist Devices
Global Artificial Heart and Ventricular Assist Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Heart and Ventricular Assist Devices Market Segment Percentages, by Application, 2021 (%)
Coronary Heart Disease
Cerebrovascular Disease
Peripheral Arterial Disease
Rheumatic Heart Disease
Congenital Heart Disease
Deep Vein Thrombosis
Other
Global Artificial Heart and Ventricular Assist Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Heart and Ventricular Assist Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Heart and Ventricular Assist Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Artificial Heart and Ventricular Assist Devices revenues share in global market, 2021 (%)
Key companies Artificial Heart and Ventricular Assist Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Artificial Heart and Ventricular Assist Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
SynCardia Systems
Medtronic PLC
Abbott Laboratories
BiVACOR
Berlin Heart
ABIOMED
LivaNova PLC
CARMAT
Jarvik Heart Inc
Chongqing Yongrenxin Medical
Thoratec
Cleveland Heart
CryoLife